Living in the MiFID world

It is almost six months since MiFID II went live, Optimum Strategic Communications and Bloomberg Intelligence, Bloomberg L.P.’s research arm, will host a lunchtime event to discuss the impact of MiFID II and what companies and investors are experiencing. The event will include panel discussions with large and small cap healthcare companies and investors in the healthcare sector.


Co-hosted


When & where

Thursday, 14 June 2018
12:00pm – 4:00pm

Bloomberg L.P.
3 Queen Victoria Street
London, EC4N 4TQ
Map


Featured speakers

Oliver Maier
Head of IR
Bayer

Rachel Graveson
Head of IR
Genmab

Ingeborg Oie
Head of IR
Smith & Nephew

Karl Hård
Head of Investor Relations
Kiadis Pharma


View full list of speakers


Register